Agency Information Collection Activities; Proposed Collection; Comment Request; Current Good Manufacturing Practice Regulations for Medicated Feeds, 7741-7743 [2023-02446]
Download as PDF
Federal Register / Vol. 88, No. 24 / Monday, February 6, 2023 / Notices
Dated: February 1, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2023–02482 Filed 2–3–23; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2010–N–0601]
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Current Good
Manufacturing Practice Regulations for
Medicated Feeds
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA or Agency) is
announcing an opportunity for public
comment on the proposed collection of
certain information by the Agency.
Under the Paperwork Reduction Act of
1995 (PRA), Federal agencies are
required to publish notice in the
Federal Register concerning each
proposed collection of information,
including each proposed extension of an
existing collection of information, and
to allow 60 days for public comment in
response to the notice. This notice
solicits comments on the recordkeeping
requirements for manufacturers of
medicated animal feeds.
DATES: Either electronic or written
comments on the collection of
information must be submitted by April
7, 2023.
ADDRESSES: You may submit comments
as follows. Please note that late,
untimely filed comments will not be
considered. The https://
www.regulations.gov electronic filing
system will accept comments until
11:59 p.m. Eastern Time at the end of
April 7, 2023. Comments received by
mail/hand delivery/courier (for written/
paper submissions) will be considered
timely if they are received on or before
that date.
DDrumheller on DSK120RN23PROD with NOTICES
SUMMARY:
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
VerDate Sep<11>2014
18:51 Feb 03, 2023
Jkt 259001
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand Delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2010–N–0601 for ‘‘Agency Information
Collection Activities; Proposed
Collection; Comment Request; Current
Good Manufacturing Practice
Regulations for Medicated Feeds.’’
Received comments, those filed in a
timely manner (see ADDRESSES), will be
placed in the docket and, except for
those submitted as ‘‘Confidential
Submissions,’’ publicly viewable at
https://www.regulations.gov or at the
Dockets Management Staff between 9
a.m. and 4 p.m., Monday through
Friday, 240–402–7500.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ The
Agency will review this copy, including
the claimed confidential information, in
its consideration of comments. The
second copy, which will have the
claimed confidential information
redacted/blacked out, will be available
for public viewing and posted on
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
7741
https://www.regulations.gov. Submit
both copies to the Dockets Management
Staff. If you do not wish your name and
contact information to be made publicly
available, you can provide this
information on the cover sheet and not
in the body of your comments and you
must identify this information as
‘‘confidential.’’ Any information marked
as ‘‘confidential’’ will not be disclosed
except in accordance with 21 CFR 10.20
and other applicable disclosure law. For
more information about FDA’s posting
of comments to public dockets, see 80
FR 56469, September 18, 2015, or access
the information at: https://
www.govinfo.gov/content/pkg/FR-201509-18/pdf/2015-23389.pdf.
Docket: For access to the docket to
read background documents or the
electronic and written/paper comments
received, go to https://
www.regulations.gov and insert the
docket number, found in brackets in the
heading of this document, into the
‘‘Search’’ box and follow the prompts
and/or go to the Dockets Management
Staff, 5630 Fishers Lane, Rm. 1061,
Rockville, MD 20852, 240–402–7500.
FOR FURTHER INFORMATION CONTACT:
Amber Sanford, Office of Operations,
Food and Drug Administration, Three
White Flint North, 10A–12M, 11601
Landsdown St., North Bethesda, MD
20852, 301–796–8867, PRAStaff@
fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Under the
PRA (44 U.S.C. 3501–3521), Federal
agencies must obtain approval from the
Office of Management and Budget
(OMB) for each collection of
information they conduct or sponsor.
‘‘Collection of information’’ is defined
in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes Agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA (44
U.S.C. 3506(c)(2)(A)) requires Federal
agencies to provide a 60-day notice in
the Federal Register concerning each
proposed collection of information,
including each proposed extension of an
existing collection of information,
before submitting the collection to OMB
for approval. To comply with this
requirement, FDA is publishing notice
of the proposed collection of
information set forth in this document.
With respect to the following
collection of information, FDA invites
comments on these topics: (1) whether
the proposed collection of information
is necessary for the proper performance
of FDA’s functions, including whether
the information will have practical
utility; (2) the accuracy of FDA’s
E:\FR\FM\06FEN1.SGM
06FEN1
7742
Federal Register / Vol. 88, No. 24 / Monday, February 6, 2023 / Notices
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and
assumptions used; (3) ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques,
when appropriate, and other forms of
information technology.
Current Good Manufacturing Practice
Regulations for Medicated Feeds—21
CFR Part 225
OMB Control Number 0910–0152—
Extension
Under section 501 of the Federal
Food, Drug, and Cosmetic Act (FD&C
Act) (21 U.S.C. 351), FDA has the
statutory authority to issue current good
manufacturing practice (CGMP)
regulations for drugs, including
medicated feeds. Medicated feeds are
administered to animals for the
prevention, cure, mitigation, or
treatment of disease, or growth
criteria in part 225 to determine
whether the systems and procedures
used by manufacturers of medicated
feeds are adequate to ensure that their
feeds meet the requirements of the
FD&C Act as to safety, and also that they
meet their claimed identity, strength,
quality, and purity, as required by
section 501(a)(2)(B) of the FD&C Act.
promotion and feed efficiency. Statutory
requirements for CGMPs have been
codified under part 225 (21 CFR part
225). Medicated feeds that are not
manufactured in accordance with these
regulations are considered adulterated
under section 501(a)(2)(B) of the FD&C
Act. Under part 225, a manufacturer is
required to establish, maintain, and
retain records for a medicated feed,
including records to document
procedures required during the
manufacturing process to assure that
proper quality control is maintained.
Such records would, for example,
contain information concerning receipt
and inventory of drug components,
batch production, laboratory assay
results (i.e., batch and stability testing),
labels, and product distribution.
This information is needed so that
FDA can monitor drug usage and
possible misformulation of medicated
feeds to investigate violative drug
residues in products from treated
animals and to investigate product
defects when a drug is recalled. In
addition, FDA will use the CGMP
A license is required when the
manufacturer of a medicated feed
involves the use of a drug or drugs that
FDA has determined requires more
control because of the need for a
withdrawal period before slaughter or
because of carcinogenic concerns.
Conversely, a license is not required,
and the recordkeeping requirements are
less demanding, for those medicated
feeds for which FDA has determined
that the drugs used in their manufacture
need less control. Respondents to this
collection of information are
commercial feed mills and mixers/
feeders.
FDA estimates the burden of this
collection of information as follows:
TABLE 1—ESTIMATED ANNUAL RECORDKEEPING BURDEN—REGISTERED LICENSED COMMERCIAL FEED MILLS 1
Number of
respondents
21 CFR part
Number of
responses per
respondent
Total annual
responses
Average burden per
response
Total hours
225.42(b)(5) through (8) requires records of receipt, storage, and inventory control of medicated feeds.
225.58(c) and (d) requires records of the results of periodic assays for
medicated feeds that are in accord with label specifications and also
those medicated feeds not within documented permissible assay limits.
225.80(b)(2) requires that verified medicated feed label(s) be kept for 1
year.
225.102(b)(1) through (5), requires records of master record files and
production records for medicated feeds.
225.110(b)(1) and (2) requires maintenance of distribution records for
medicated feeds.
225.115(b)(1) and (2) requires maintenance of complaint files by the
medicated feed manufacturer.
791
260
205,660
1 ..................................
205,660
791
45
35,595
0.50 (30 minutes) .......
17,798
791
1,600
1,265,600
0.12 (7 minutes) .........
151,872
791
7,800
6,169,800
0.08 (5 minutes) .........
493,584
791
7,800
6,169,800
0.02 (1 minute) ...........
123,396
791
5
3,955
0.12 (7 minutes) .........
475
Total ......................................................................................................
........................
........................
........................
.....................................
992,785
1 There
are no capital costs or operating and maintenance costs associated with this collection of information.
TABLE 2—ESTIMATED ANNUAL RECORDKEEPING BURDEN—REGISTERED LICENSED MIXER/FEEDERS 1
DDrumheller on DSK120RN23PROD with NOTICES
Number of
records per
recordkeeper
Number of
recordkeepers
21 CFR part
Total annual
records
Average burden per
recordkeeping
Total hours
225.42(b)(5) through (8) requires records of receipt, storage, and inventory control of medicated feeds.
225.58(c) and (d) requires records of the results of periodic assays for
medicated feeds that are in accord with label specifications and also
those medicated feeds not within documented permissible assay limits.
225.80(b)(2) requires that verified medicated feed label(s) be kept for 1
year.
225.102(b)(1) through (5) requires records of master record files and production records for medicated feeds.
100
260
26,000
0.15 (9 minutes) .........
3,900
100
36
3,600
0.50 (30 minutes) .......
1,800
100
48
4,800
0.12 (7 minutes) .........
576
100
260
26,000
0.40 (24 minutes) .......
10,400
Total ......................................................................................................
........................
........................
........................
.....................................
16,676
1 There
are no capital costs or operating and maintenance costs associated with this collection of information.
VerDate Sep<11>2014
18:51 Feb 03, 2023
Jkt 259001
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
E:\FR\FM\06FEN1.SGM
06FEN1
7743
Federal Register / Vol. 88, No. 24 / Monday, February 6, 2023 / Notices
TABLE 3—ESTIMATED ANNUAL RECORDKEEPING BURDEN—NONREGISTERED NON-LICENSED COMMERCIAL FEED MILLS 1
Number of
records per
recordkeeper
Number of
recordkeepers
21 CFR section
Total annual
records
Average burden per
recordkeeping
Total hours
225.142 requires procedures for identification, storage, and inventory
control (receipt and use) of Type A medicated articles and Type B
medicated feeds.
225.158 requires records of investigation and corrective action when the
results of laboratory assays of drug components indicate that the medicated feed is not in accord with the permissible assay limits.
225.180 requires identification, storage, and inventory control of labeling
in a manner that prevents label mix-ups and assures that correct labels
are used for medicated feeds.
225.202 requires records of formulation, production, and distribution of
medicated feeds.
4,357
4
17,428
1 ..................................
17,428
4,357
1
4,357
4 ..................................
17,428
4,357
96
418,272
0.12 (7 minutes) .........
50,193
4,357
260
1,132,820
0.65 (39 minutes) .......
736,333
Total ......................................................................................................
........................
........................
........................
.....................................
821,382
1 There
are no capital costs or operating and maintenance costs associated with this collection of information.
TABLE 4—ESTIMATED ANNUAL RECORDKEEPING BURDEN—NONREGISTERED NON-LICENSED MIXER/FEEDERS 1
Total annual
records
Average burden per
recordkeeper
Total hours
225.142 requires procedures for identification, storage, and inventory
control (receipt and use) of Type A medicated articles and Type B
medicated feeds.
225.158 requires records of investigation and corrective action when the
results of laboratory assays of drug components indicate that the medicated feed is not in accord with the permissible assay limits.
225.180 requires identification, storage, and inventory control of labeling
in a manner that prevents label mix-ups and assures that correct labels
are used for medicated feeds.
225.202 requires records of formulation, production, and distribution of
medicated feeds.
3,400
4
13,600
1 ..................................
13,600
3,400
1
3,400
4 ..................................
13,600
3,400
32
108,800
0.12 (7 minutes) .........
13,056
3,400
260
884,000
0.33 (20 minutes) .......
291,720
Total ......................................................................................................
........................
........................
........................
.....................................
331,976
1 There
are no capital costs or operating and maintenance costs associated with this collection of information.
Our estimated burden for the
information collection reflects an
overall decrease of 10,435 hours and an
increase of 831,545 records since last
OMB approval. We attribute this
adjustment due to an increase in the
number of non-registered, non-licensed
commercial medicated feed mills and
decrease in non-licensed medicated feed
mill recordkeeping the last few years.
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Dated: February 1, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
Name of Committee: National Center for
Complementary and Integrative Health
Special Emphasis Panel; Research Resource
Center to Build an Open-Access Repository
and Database for Anatomical and
Physiological Correlates of Acupoints (U24,
Clinical Trial Optional).
Date: March 3, 2023.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate
cooperative agreement applications.
Place: National Center for Complementary
and Integrative Democracy II, 6707
Democracy Blvd., Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Shiyong Huang, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, Division of Extramural Activities,
NCCIH/NIH, 6707 Democracy Boulevard,
Suite 401, Bethesda, MD 20817,
shiyong.huang@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.213, Research and Training
[FR Doc. 2023–02446 Filed 2–3–23; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
DDrumheller on DSK120RN23PROD with NOTICES
Number of
records per
recordkeeper
Number of
recordkeepers
21 CFR section
National Center for Complementary &
Integrative Health; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
VerDate Sep<11>2014
18:51 Feb 03, 2023
Jkt 259001
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
in Complementary and Alternative Medicine,
National Institutes of Health, HHS)
Dated: February 1, 2023.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–02462 Filed 2–3–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request; Information
Program on Clinical Trials: Maintaining
a Registry and Results Databank
(National Library of Medicine)
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
In compliance with the
Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has
submitted to the Office of Management
and Budget (OMB) a request for review
and approval of the information
collection listed below.
SUMMARY:
E:\FR\FM\06FEN1.SGM
06FEN1
Agencies
[Federal Register Volume 88, Number 24 (Monday, February 6, 2023)]
[Notices]
[Pages 7741-7743]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-02446]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2010-N-0601]
Agency Information Collection Activities; Proposed Collection;
Comment Request; Current Good Manufacturing Practice Regulations for
Medicated Feeds
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA or Agency) is announcing
an opportunity for public comment on the proposed collection of certain
information by the Agency. Under the Paperwork Reduction Act of 1995
(PRA), Federal agencies are required to publish notice in the Federal
Register concerning each proposed collection of information, including
each proposed extension of an existing collection of information, and
to allow 60 days for public comment in response to the notice. This
notice solicits comments on the recordkeeping requirements for
manufacturers of medicated animal feeds.
DATES: Either electronic or written comments on the collection of
information must be submitted by April 7, 2023.
ADDRESSES: You may submit comments as follows. Please note that late,
untimely filed comments will not be considered. The https://www.regulations.gov electronic filing system will accept comments until
11:59 p.m. Eastern Time at the end of April 7, 2023. Comments received
by mail/hand delivery/courier (for written/paper submissions) will be
considered timely if they are received on or before that date.
Electronic Submissions
Submit electronic comments in the following way:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments. Comments submitted
electronically, including attachments, to https://www.regulations.gov
will be posted to the docket unchanged. Because your comment will be
made public, you are solely responsible for ensuring that your comment
does not include any confidential information that you or a third party
may not wish to be posted, such as medical information, your or anyone
else's Social Security number, or confidential business information,
such as a manufacturing process. Please note that if you include your
name, contact information, or other information that identifies you in
the body of your comments, that information will be posted on https://www.regulations.gov.
If you want to submit a comment with confidential
information that you do not wish to be made available to the public,
submit the comment as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').
Written/Paper Submissions
Submit written/paper submissions as follows:
Mail/Hand Delivery/Courier (for written/paper
submissions): Dockets Management Staff (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
For written/paper comments submitted to the Dockets
Management Staff, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
Instructions: All submissions received must include the Docket No.
FDA-2010-N-0601 for ``Agency Information Collection Activities;
Proposed Collection; Comment Request; Current Good Manufacturing
Practice Regulations for Medicated Feeds.'' Received comments, those
filed in a timely manner (see ADDRESSES), will be placed in the docket
and, except for those submitted as ``Confidential Submissions,''
publicly viewable at https://www.regulations.gov or at the Dockets
Management Staff between 9 a.m. and 4 p.m., Monday through Friday, 240-
402-7500.
Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will
review this copy, including the claimed confidential information, in
its consideration of comments. The second copy, which will have the
claimed confidential information redacted/blacked out, will be
available for public viewing and posted on https://www.regulations.gov.
Submit both copies to the Dockets Management Staff. If you do not wish
your name and contact information to be made publicly available, you
can provide this information on the cover sheet and not in the body of
your comments and you must identify this information as
``confidential.'' Any information marked as ``confidential'' will not
be disclosed except in accordance with 21 CFR 10.20 and other
applicable disclosure law. For more information about FDA's posting of
comments to public dockets, see 80 FR 56469, September 18, 2015, or
access the information at: https://www.govinfo.gov/content/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane,
Rm. 1061, Rockville, MD 20852, 240-402-7500.
FOR FURTHER INFORMATION CONTACT: Amber Sanford, Office of Operations,
Food and Drug Administration, Three White Flint North, 10A-12M, 11601
Landsdown St., North Bethesda, MD 20852, 301-796-8867,
[email protected].
SUPPLEMENTARY INFORMATION: Under the PRA (44 U.S.C. 3501-3521), Federal
agencies must obtain approval from the Office of Management and Budget
(OMB) for each collection of information they conduct or sponsor.
``Collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes Agency requests or requirements that members of
the public submit reports, keep records, or provide information to a
third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A))
requires Federal agencies to provide a 60-day notice in the Federal
Register concerning each proposed collection of information, including
each proposed extension of an existing collection of information,
before submitting the collection to OMB for approval. To comply with
this requirement, FDA is publishing notice of the proposed collection
of information set forth in this document.
With respect to the following collection of information, FDA
invites comments on these topics: (1) whether the proposed collection
of information is necessary for the proper performance of FDA's
functions, including whether the information will have practical
utility; (2) the accuracy of FDA's
[[Page 7742]]
estimate of the burden of the proposed collection of information,
including the validity of the methodology and assumptions used; (3)
ways to enhance the quality, utility, and clarity of the information to
be collected; and (4) ways to minimize the burden of the collection of
information on respondents, including through the use of automated
collection techniques, when appropriate, and other forms of information
technology.
Current Good Manufacturing Practice Regulations for Medicated Feeds--21
CFR Part 225
OMB Control Number 0910-0152--Extension
Under section 501 of the Federal Food, Drug, and Cosmetic Act (FD&C
Act) (21 U.S.C. 351), FDA has the statutory authority to issue current
good manufacturing practice (CGMP) regulations for drugs, including
medicated feeds. Medicated feeds are administered to animals for the
prevention, cure, mitigation, or treatment of disease, or growth
promotion and feed efficiency. Statutory requirements for CGMPs have
been codified under part 225 (21 CFR part 225). Medicated feeds that
are not manufactured in accordance with these regulations are
considered adulterated under section 501(a)(2)(B) of the FD&C Act.
Under part 225, a manufacturer is required to establish, maintain, and
retain records for a medicated feed, including records to document
procedures required during the manufacturing process to assure that
proper quality control is maintained. Such records would, for example,
contain information concerning receipt and inventory of drug
components, batch production, laboratory assay results (i.e., batch and
stability testing), labels, and product distribution.
This information is needed so that FDA can monitor drug usage and
possible misformulation of medicated feeds to investigate violative
drug residues in products from treated animals and to investigate
product defects when a drug is recalled. In addition, FDA will use the
CGMP criteria in part 225 to determine whether the systems and
procedures used by manufacturers of medicated feeds are adequate to
ensure that their feeds meet the requirements of the FD&C Act as to
safety, and also that they meet their claimed identity, strength,
quality, and purity, as required by section 501(a)(2)(B) of the FD&C
Act.
A license is required when the manufacturer of a medicated feed
involves the use of a drug or drugs that FDA has determined requires
more control because of the need for a withdrawal period before
slaughter or because of carcinogenic concerns. Conversely, a license is
not required, and the recordkeeping requirements are less demanding,
for those medicated feeds for which FDA has determined that the drugs
used in their manufacture need less control. Respondents to this
collection of information are commercial feed mills and mixers/feeders.
FDA estimates the burden of this collection of information as
follows:
Table 1--Estimated Annual Recordkeeping Burden--Registered Licensed Commercial Feed Mills \1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of
21 CFR part Number of responses per Total annual Average burden per response Total hours
respondents respondent responses
--------------------------------------------------------------------------------------------------------------------------------------------------------
225.42(b)(5) through (8) requires records of 791 260 205,660 1......................................... 205,660
receipt, storage, and inventory control of
medicated feeds.
225.58(c) and (d) requires records of the 791 45 35,595 0.50 (30 minutes)......................... 17,798
results of periodic assays for medicated feeds
that are in accord with label specifications
and also those medicated feeds not within
documented permissible assay limits.
225.80(b)(2) requires that verified medicated 791 1,600 1,265,600 0.12 (7 minutes).......................... 151,872
feed label(s) be kept for 1 year.
225.102(b)(1) through (5), requires records of 791 7,800 6,169,800 0.08 (5 minutes).......................... 493,584
master record files and production records for
medicated feeds.
225.110(b)(1) and (2) requires maintenance of 791 7,800 6,169,800 0.02 (1 minute)........................... 123,396
distribution records for medicated feeds.
225.115(b)(1) and (2) requires maintenance of 791 5 3,955 0.12 (7 minutes).......................... 475
complaint files by the medicated feed
manufacturer.
--------------------------------------------------------------------------------------------------------
Total...................................... .............. .............. .............. .......................................... 992,785
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.
Table 2--Estimated Annual Recordkeeping Burden--Registered Licensed Mixer/Feeders \1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of
21 CFR part Number of records per Total annual Average burden per recordkeeping Total hours
recordkeepers recordkeeper records
--------------------------------------------------------------------------------------------------------------------------------------------------------
225.42(b)(5) through (8) requires records of 100 260 26,000 0.15 (9 minutes).......................... 3,900
receipt, storage, and inventory control of
medicated feeds.
225.58(c) and (d) requires records of the 100 36 3,600 0.50 (30 minutes)......................... 1,800
results of periodic assays for medicated feeds
that are in accord with label specifications
and also those medicated feeds not within
documented permissible assay limits.
225.80(b)(2) requires that verified medicated 100 48 4,800 0.12 (7 minutes).......................... 576
feed label(s) be kept for 1 year.
225.102(b)(1) through (5) requires records of 100 260 26,000 0.40 (24 minutes)......................... 10,400
master record files and production records for
medicated feeds.
--------------------------------------------------------------------------------------------------------
Total...................................... .............. .............. .............. .......................................... 16,676
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.
[[Page 7743]]
Table 3--Estimated Annual Recordkeeping Burden--Nonregistered Non-Licensed Commercial Feed Mills \1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of
21 CFR section Number of records per Total annual Average burden per recordkeeping Total hours
recordkeepers recordkeeper records
--------------------------------------------------------------------------------------------------------------------------------------------------------
225.142 requires procedures for identification, 4,357 4 17,428 1......................................... 17,428
storage, and inventory control (receipt and
use) of Type A medicated articles and Type B
medicated feeds.
225.158 requires records of investigation and 4,357 1 4,357 4......................................... 17,428
corrective action when the results of
laboratory assays of drug components indicate
that the medicated feed is not in accord with
the permissible assay limits.
225.180 requires identification, storage, and 4,357 96 418,272 0.12 (7 minutes).......................... 50,193
inventory control of labeling in a manner that
prevents label mix-ups and assures that
correct labels are used for medicated feeds.
225.202 requires records of formulation, 4,357 260 1,132,820 0.65 (39 minutes)......................... 736,333
production, and distribution of medicated
feeds.
--------------------------------------------------------------------------------------------------------
Total...................................... .............. .............. .............. .......................................... 821,382
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.
Table 4--Estimated Annual Recordkeeping Burden--Nonregistered Non-Licensed Mixer/Feeders \1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of
21 CFR section Number of records per Total annual Average burden per recordkeeper Total hours
recordkeepers recordkeeper records
--------------------------------------------------------------------------------------------------------------------------------------------------------
225.142 requires procedures for identification, 3,400 4 13,600 1......................................... 13,600
storage, and inventory control (receipt and
use) of Type A medicated articles and Type B
medicated feeds.
225.158 requires records of investigation and 3,400 1 3,400 4......................................... 13,600
corrective action when the results of
laboratory assays of drug components indicate
that the medicated feed is not in accord with
the permissible assay limits.
225.180 requires identification, storage, and 3,400 32 108,800 0.12 (7 minutes).......................... 13,056
inventory control of labeling in a manner that
prevents label mix-ups and assures that
correct labels are used for medicated feeds.
225.202 requires records of formulation, 3,400 260 884,000 0.33 (20 minutes)......................... 291,720
production, and distribution of medicated
feeds.
--------------------------------------------------------------------------------------------------------
Total...................................... .............. .............. .............. .......................................... 331,976
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.
Our estimated burden for the information collection reflects an
overall decrease of 10,435 hours and an increase of 831,545 records
since last OMB approval. We attribute this adjustment due to an
increase in the number of non-registered, non-licensed commercial
medicated feed mills and decrease in non-licensed medicated feed mill
recordkeeping the last few years.
Dated: February 1, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2023-02446 Filed 2-3-23; 8:45 am]
BILLING CODE 4164-01-P